Pith. sign in

REVIEW 3 major objections 5 minor 45 references

A Fourfold Pathogen Reference Ontology Suite

T0 review · 3 major / 5 minor · reviewed 2026-08-10 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read This paper claims that four pathogen-specific reference ontologies—VIDO, BIDO, MIDO, and PIDO—form a needed intermediate layer between the general Infectious Disease Ontology and disease-level ontologies.

desk verdict Useful new reference ontologies for the IDO ecosystem, but a definitional slip in MIDO and PIDO disease courses undercuts the suite's core design pattern. read the letter →

arxiv 2501.01454 v3 pith:O2CHR5G3 submitted 2024-12-31 q-bio.OT cs.AIcs.LO

Shane Babcock , Carter Benson , Giacomo De Colle , Sydney Cohen , Alexander D. Diehl , Ram A.N.R. Challa , Ray Mavrovich , Joshua Billig
show 3 more authors
Anthony Huffman Yongqun He John Beverley
This is my paper · ORCID
classification q-bio.OTcs.AIcs.LO
keywords infectiousdiseaseontologypathogenreferencehub-and-spokemethodologyVIDOBIDOMIDOPIDOmodularization
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper claims that infectious disease data needs an intermediate semantic layer between the very general Infectious Disease Ontology (IDO) and ontologies for particular diseases, and that this layer is best built as four pathogen-specific reference ontologies: one each for viruses, bacteria, fungi, and parasites. Following a 'hub-and-spoke' methodology, each ontology imports shared terms from IDO and adds pathogen-specific classes defined with the pattern 'A is a B that C's.' The four ontologies—VIDO, BIDO, MIDO, and PIDO—are meant to act as guardrails so that disease-level ontologies can be built faster, stay aligned with each other, and reuse vetted definitions rather than starting from scratch. A sympathetic reader would care because this is a concrete proposal for making infectious-disease datasets comparable across pathogen types, with the COVID-19 experience as the motivating case for updating and modularizing the IDO ecosystem.

What carries the argument

The load-bearing mechanism is the 'hub-and-spoke' design pattern combined with the IDO/OGMS definition template 'A is a B that C's': each new class is defined as a subclass of a parent imported from IDO or another ontology, with a differentiating clause specifying what makes it specific. Around this template, the suite builds the disorder-infection-disease-disease-course spine inherited from IDO, and adds pathogen-type classifications based on dispositions (e.g., infectious structure as acellular structure bearing an infectious disposition; pathogen as material entity bearing a pathogenic disposition). OWL 2 with automated reasoning, plus SWRL rules for conditional stage ordering in VIDO and equivalency axioms such as the pilus axiom in BIDO, turn these definitions into inferable classifications rather than merely labeled hierarchies.

What would settle it

An automated reasoning test on BIDO that classifies a stated case of non-infectious food-borne botulism as a bacterial infectious disorder would show the assumed template distorts the domain; similarly, a PIDO alignment of the existing malaria and schistosomiasis ontologies that cannot represent the parasite vector as a host-pathogen-vector tripartite relation would falsify the suite's claim of guarding parasite domain modeling.

Watch

Extended reading notes

Core claim

The central claim is that creating pathogen-specific reference ontologies advances modularization and reusability within the IDO ecosystem, with each of VIDO, BIDO, MIDO, and PIDO occupying a 'middle' position: more specific than IDO, more general than a disease-level ontology. The paper reports the scope, major classes, and relations of each ontology, and shows how they are assembled by reusing terms from IDO and other ontologies and adding new defined classes. Concretely, VIDO classifies viruses by Baltimore class and by infectious disposition, and models the virus replication cycle with SWRL rules that order stages conditionally; BIDO distinguishes bacterial toxin disorder from bacterial infectious disorder so that food-borne botulism is not misclassified as an infection; MIDO introduces yeast, mold, and dimorphic fungus, and formalizes opportunistic fungal pathogen with an axiom restricting realization to non-immunocompetent hosts; PIDO separates infection-causing from disease-causing parasite life stages, which lets one model diseases like schistosomiasis where infection and disease are caused by different stages. The paper concludes that these four ontologies provide 'guardrails' that save researchers time and effort when building domain ontologies, just as libraries save programmers from rewriting common code.

Load-bearing premise

The paper assumes that one definitional template built around IDO's disorder and infection classes fits all four pathogen types without distortion, including bacterial toxin-mediated disease that is not an infection and parasite life stages that change phenotype between infection and disease.

Editorial extensions

If this is right

  • Legacy IDO extensions such as the influenza, HIV, dengue, staphylococcus, brucellosis, meningitis, malaria, and schistosomiasis ontologies can be refactored to import from the matching reference ontology, bringing them into alignment with updated IDO and BFO.
  • Researchers building a new pathogen-specific disease ontology can start from vetted intermediate classes instead of modeling from the top down, which the paper argues saves time and reduces errors.
  • The suite's common definitions for infection, infectious disorder, infectious disease, and disease course make it possible to compare and integrate data across virus, bacterium, fungus, and parasite disease domains.
  • Ontology developers can use automated reasoners to infer classifications, such as recognizing a pilus as both an adhesion factor and a virulence factor, or recognizing a positive-sense RNA virus's translation stage as preceding transcription in a replication cycle.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The BIDO distinction between bacterial toxin disorder and bacterial infectious disorder suggests a reusable template for non-infectious toxin-mediated diseases generally, which could be extended to food safety and environmental health ontologies.
  • The VIDO SWRL pattern for conditional stage ordering is a general trick for representing branching life cycles in OWL, and could be carried over to parasite vector cycles where the same pathogen has different hosts at different stages.
  • If the suite is adopted, one measurable payoff is reduced definitional drift: aligned domain ontologies should share more term reuse and fewer conflicting definitions than the legacy extensions, a claim future studies could test.
  • The coordination infrastructure described (a shared GitHub organization, CI/CD, term-request workflows) implies the suite's real product is not just four ontologies but a governance process for keeping them consistent, which is where the project's long-term value would lie.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 5 minor

Summary. The paper introduces a suite of four OBO-style reference ontologies extending the Infectious Disease Ontology (IDO): VIDO, BIDO, MIDO, and PIDO. The stated aim is to provide an intermediate semantic layer between IDO and pathogen-specific domain ontologies, using a hub-and-spoke methodology, with BFO/IDO design patterns and reuse of terms from GO, PRO, ChEBI, MONDO, and others. The authors report ontology size and reuse statistics, describe major classes and design patterns (e.g., virus replication cycle, bacterial toxin vs. infectious disorder, parasite life stages), mention automated reasoning checks with HermiT and Pellet, and outline CI/CD-based governance and future extension plans. The central claim is that these reference ontologies advance modularization and reusability within the IDO ecosystem.

Significance. If the central claim is substantiated, the suite would be a useful contribution to biomedical ontology infrastructure: it responds to a real need for consistent mid-level pathogen-specific classes, the artifacts are openly available, the reasoning checks with HermiT and Pellet provide some machine-checked assurance, and the proposed CI/CD pipeline and GitHub governance are good practical steps. The paper also gives appropriate credit to existing resources (IDO, OGMS, MONDO, OPL, etc.). However, the paper currently provides no quantitative or comparative evidence that the suite improves modularity, reuse, or data integration; the claim is asserted rather than measured. In addition, a category-level definitional inconsistency in two of the four ontologies undermines the suite's internal coherence and its claim to provide a rigorous uniform reference layer.

major comments (3)
  1. [Tables 4 and 6; Results (MIDO, PIDO)] The definitions of 'fungal infectious disease course' (Table 4) and 'parasite infectious disease course' (Table 6) classify these terms as diseases: e.g., 'Infectious disease whose physical basis is a fungal disorder...' and 'Infectious disease whose physical basis is a parasite disorder...'. This contradicts the OGMS/IDO pattern explicitly adopted in Methods and correctly followed in Tables 2 and 3, where an infectious disease course is an infectious disease course that is the realization of an infectious disease (a process, not a disposition). The error conflates a disease (disposition) with a disease course (process) and would propagate a semantically inconsistent disease-course hierarchy to any downstream ontology importing MIDO or PIDO terms. The definitions should be corrected to the pattern used in VIDO and BIDO before the suite can be presented as a coherent reference layer.
  2. [Discussion and Conclusion; Abstract] The central claim that the suite 'advances modularization and reusability' is asserted rather than demonstrated. The paper provides no modularity metrics, no comparison with alternative modeling strategies, no analysis of imported-term redundancy or overlap, and no downstream application that measures reuse. The Discussion explicitly defers empirical investigation to future work ('subsequent empirical investigation'), and the Conclusion frames the value as a 'conceit'. This makes the headline conclusion currently unsupported. To substantiate the claim, the authors should either report concrete reuse or interoperability evidence (e.g., refactoring of IDOFLU/IDOMAL/IDOSCHISTO using the new reference layer, or quantitative term-reuse statistics across the ecosystem) or explicitly soften the conclusion to a design proposal.
  3. [Methods; Results (BIDO)] The BIDO distinction between 'bacterial toxin disorder' and 'bacterial infectious disorder' is well motivated, but the presentation leaves ambiguous whether 'bacterial infectious disease course' and 'bacterial pathogenesis' are asserted to be disjoint or partially overlapping. Table 3 defines 'bacterial infectious disease course' as the realization of a bacterial infectious disease, while 'bacterial pathogenesis' is defined without requiring an infection process. Since a bacterial toxin-induced non-infectious disease can have a disease course but is not an infectious disease course, the paper should make explicit whether a 'bacterial infectious disease course' can realize a disease whose basis is a bacterial toxin disorder that is not an infectious disorder. The current text suggests these are cleanly separated but does not state the logical relationship, which matters for downstream reasoning.
minor comments (5)
  1. [Throughout] Several typographical and grammatical errors should be corrected: 'an reference ontology' (Results, VIDO section), 'subject-matter matters' (Methods), 'A Fourfold Pathogen Reference Ontology Suite' repeated in the running title, and inconsistent capitalization of 'Fungus' and 'Parasite' in class definitions.
  2. [References] References 50–52 duplicate references 12, 13, and 7 with different numbering; the reference list should be deduplicated and all in-text citations rechecked. Also, some references cite 'Retrieved December 24, 2024' and 'Retrieved April 17, 2025' inconsistently; the access dates should be harmonized.
  3. [Methods; SWRL rules] The two SWRL rules in the VIDO section are presented in a way that is hard to read; the authors should consider aligning the rule syntax and explaining in prose that the rules are applied only to virions participating in the same replication cycle. Also, the paper states that OWL 'is not amenable to representing conditional scenarios' but then uses SWRL; this contrast could be clarified, since SWRL rules are themselves not part of OWL 2 DL semantics and may affect decidability.
  4. [Results (MIDO)] In the MIDO section, the axiom for 'opportunistic fungal pathogen' is written as an 'inheres in some fungus' axiom, but the class name suggests it classifies fungi, not dispositions. This should be rephrased or checked in the OWL artifact to avoid a misleading presentation of what the axiom asserts.
  5. [Availability of Data and Materials] The GitHub URLs for the four ontologies are given, but the paper does not specify version identifiers, release dates, or a hash/DOI for the exact artifacts that were reasoned over with HermiT and Pellet. Adding persistent versioning information would improve reproducibility of the reported reasoning checks.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: the ontologies' classes and definitions are stipulated from imported IDO/OGMS terms and external literature, not derived from the suite's own conclusions.

full rationale

This paper is an ontology engineering report rather than a derivation of predictions from fitted inputs. Its load-bearing content is the reuse of IDO, OGMS, BFO, and OBO Foundry classes through the explicit 'A is a B that C's' definitional pattern, and the introduction of new classes whose definitions are justified by literature review, subject-matter expert consultation, and consensus-building. No parameter is fitted to data and subsequently renamed as a prediction; no uniqueness theorem is invoked to force a choice; and no asserted result is defined into existence in terms of the suite's own conclusions. The self-citations, including the VIDO companion paper [16] and the IDO update [3], supply provenance and context for the hub-and-spoke strategy, but the definitions themselves are checkable against the cited external resources and are not used as unverified premises that secretly carry the suite's claims. The MIDO and PIDO definitions of 'fungal infectious disease course' and 'parasite infectious disease course' as diseases rather than disease courses are an internal consistency concern relative to the inherited IDO/OGMS pattern, but that is a modeling correctness issue, not circular reasoning. Accordingly, the analysis finds no circular step.

Assumptions & free parameters 0 free parameters · 3 assumptions · 0 invented entities

This paper contributes no empirical model and no free parameters. Its central claim rests on the adequacy of the BFO/IDO top-level framework and imported OBO terms, which the paper takes as given. The new classes are controlled vocabulary items, not hypothesized physical entities.

assumptions (3)
  • domain assumption BFO and IDO categories (disorder, infection, disease, disease course) are adequate for representing viral, bacterial, fungal, and parasitic disease domains.
    Invoked in the Methods hub-and-spoke paragraph and throughout the definitions of major classes in VIDO, BIDO, MIDO, and PIDO.
  • domain assumption The 'A is a B that C's' definition pattern yields definitions with the intended semantics and does not introduce inconsistencies.
    Stated in Methods and used to define new terms such as 'bacterial infectious disease' and 'fungal infectious disease course'.
  • standard math OWL 2 DL reasoners (HermiT, Pellet) correctly check consistency and satisfiability of the ontologies.
    Methods paragraph on OWL, Protégé, and Reasoners relies on standard description-logic reasoning.

how reviews work

0 comments
Cite this review

Pith. "Pith review of A Fourfold Pathogen Reference Ontology Suite." pith.science (2026). https://pith.science/paper/O2CHR5G3

@misc{pith2026250101454,
  author       = {Pith},
  title        = {Pith review of: A Fourfold Pathogen Reference Ontology Suite},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/O2CHR5G3}},
  note         = {Machine review of arXiv:2501.01454}
}
read the original abstract

Infectious diseases remain a critical global health challenge, and the integration of standardized ontologies plays a vital role in managing related data. The Infectious Disease Ontology (IDO) and its extensions, such as the Coronavirus Infectious Disease Ontology (CIDO), are essential for organizing and disseminating information related to infectious diseases. The COVID-19 pandemic highlighted the need for updating IDO and its virus-specific extensions. There is an additional need to update IDO extensions specific to bacteria, fungus, and parasite infectious diseases. We adopt the "hub and spoke" methodology to generate pathogen-specific extensions of IDO: Virus Infectious Disease Ontology (VIDO), Bacteria Infectious Disease Ontology (BIDO), Mycosis Infectious Disease Ontology (MIDO), and Parasite Infectious Disease Ontology (PIDO). The creation of pathogen-specific reference ontologies advances modularization and reusability of infectious disease data within the IDO ecosystem. Future work will focus on further refining these ontologies, creating new extensions, and developing application ontologies based on them, in line with ongoing efforts to standardize biological and biomedical terminologies for improved data sharing and analysis.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

45 extracted references · 34 canonical work pages

  1. [1]

    The Brucellosis Infectious Disease Ontology (IDOBRU) [60] 20 A Fourfold Pathogen Reference Ontology Suite

    Staphylococcus aureus Infectious Disease Ontology (IDO-Staph) [59] 2. The Brucellosis Infectious Disease Ontology (IDOBRU) [60] 20 A Fourfold Pathogen Reference Ontology Suite

    work page

  2. [3]

    pathogen

    The Meningitis Infectious Disease Ontology (IDOMEN) [61] 4. The Bacterial Clinical Infectious Disease Ontology (BCIDO) [62, 63] Each requires updating to the most recent versions of IDO and BFO, during which refactoring to support BIDO as a common reference ontology can be conducted. This seems particularly impactful for BCIDO, designed to represent withi...

    work page

  3. [4]

    anchored in

    Malaria Infectious Disease Ontology (IDOMAL) [89] 2. The Schistosomiasis Ontology (IDOSCHISTO) [90] Each requires updating to the most recent versions of IDO and BFO, during which refactoring to support PIDO as a common reference ontology can be conducted. Developers of IDOMAL were challenged by the question of how best to model host, pathogen, and vector...

    2015

  4. [7]

    The Influenza Infectious Disease Ontology (I-IDO)

    Luciano J, Schriml L, Squires B, Scheuermann R. The Influenza Infectious Disease Ontology (I-IDO). The 11th Annual Bio-Ontologies Meeting, ISMB . 2008, 20 July; Toronto, Canada

    work page 2008

  5. [8]

    Classifying Processes: An Essay in Applied Ontology

    Smith, B. Classifying Processes: An Essay in Applied Ontology. Ratio.2012. (4):463-488. 9. Smith, B. On Classifying Material Entities in Basic Formal Ontology. Interdisciplinary Ontology: Proceedings of the Third Interdisciplinary Ontology Meeting. Tokyo: Keio University Press. 2012. 1-13

    work page 2012

  6. [18]

    A Community Effort for COVID-19 Ontology Harmonization

    Lin AY, Yamagata Y, Duncan WD, Carmody LC, Kushida T, Masuya H, Beverley J, Biswanath D, DeBellis M, Pendlington ZM, Roncaglia P, He Y. A Community Effort for COVID-19 Ontology Harmonization. The 12th International Conference on Biomedical Ontologies

    work page

  7. [20]

    OBO Foundry. (n.d.). Common Ontology of Basic Formal Ontology (COB) . Retrieved December 24, 2024, from https://obofoundry.org/COB/ 21. Shearer R, Motik B, Horrocks I, editors. HermiT: A Highly-Efficient OWL Reasoner. OWLED; 2008. 22. Evren Sirin BP, Bernardo Grau C, Kalyanpur Aditya, Yarden Katz. Pellet: A practical OWL-DL reasoner Web Semantics: Science...

    work page 2024

  8. [23]

    Survey-based naming conventions for use in OBO Foundry ontology development

    Schober D, Smith B, Lewis SE, Kusnierczyk W, Lomax J, Mungall C, et al. Survey-based naming conventions for use in OBO Foundry ontology development. BMC Bioinformatics. 2009; 10:125. Epub 2009/04/29. 1471-2105-1 24. Seppala, S., Ruttenberg, A., Schreiber, Y., Smith, B. (2016). Definitions in Ontologies . Cahiers de Lexicologie. 109(2):175-207

    work page 2016

Show all 45 references
  1. [25]

    The Gene Ontology Resource: 20 years and still GOing

    The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing. Nucleic Acids Res . 2019; 47:D330–D338. doi:10.1093/nar/gky1055

    2019 doi

  2. [26]

    A., Arighi, C

    Natale, D. A., Arighi, C. N., Blake, J. A., Bona, J., Chen, C., Chen, S. C., Christie, K. R., Cowart, J., D'Eustachio, P., Diehl, A. D., Drabkin, H. J., Duncan, W. D., Huang, H., Ren, J., Ross, K., Ruttenberg, A., Shamovsky, V., Smith, B., Wang, Q., Zhang, J., … Wu, C. H. (201...

    2017 doi

  3. [28]

    Ceusters, W., & Smith, B. (2010). Foundations for a realist ontology of mental disease. Journal of biomedical semantics , 1 (1), 10. https://doi.org/10.1186/2041-1480-1-10 29. OBO Foundry. (n.d.). MONDO Disease Ontology (MONDO) . Retrieved April 17, 2025, from https://mondo.mo...

    2010 doi

  4. [31]

    ChEBI: a database and ontology for chemical entities of biological interest

    Degtyarenko K, Matos P, Ennis M, et al. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res . 2008; 36:D344-D350. doi: 10.1093/nar/ gkm791

    2008 doi

  5. [32]

    Hastings, J. et al. ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic acids research 44, D1214-1219, doi:10.1093/nar/gkv1031 (2016)

    2016 doi

  6. [33]

    Dooley, D.M., Griffiths, E.J., Gosal, G.S. et al. FoodOn: a harmonized food ontology to increase global food traceability, quality control and data integration. npj Sci Food 2 , 23 (2018). 34. Vasilevsky, N.A., Matentzoglu, N.A., Toro, S., Flack, J.E., Hegde, H., Unni, D.R., A...

    2018

  7. [35]

    Ong, E., Xiang, Z., Zhao, B., Liu, Y., Lin, Y., Zheng, J., Mungall, C., Courtot, M., Ruttenberg, A., & He, Y. (2017). Ontobee: A linked ontology data server to support ontology term dereferencing, linkage, query and integration. Nucleic acids research , 45 (D1), D347–D352. htt...

    2017 doi

  8. [37]

    Baltimore D. (1971). Expression of Animal Virus Genomes. Bacteriological Reviews. 35, 235–41. https://doi.org/10.1128/br.35.3.235-241.1971 PMID: 4329869

    1971 doi

  9. [38]

    Bauman, R. (2017). Microbiology with Disease Taxonomy . Pearson Publishing. 39. Claverie, J.M. (2008) Encyclopedia of Virology 3 rd Edition 40. Dimmock, N.J., et. al. (2007). Introduction to Modern Virology . 6 th edition. Blackwell Publishing. 41. Cann, A. (2016). Principles ...

    2017 doi

  10. [43]

    Payne S. (2017). Introduction to RNA Viruses. Viruses , 97–105. https://doi.org/10.1016/B978-0-12-803109-4.00010-6 44. Lan, H. (2004). SWRL : A semantic Web rule language combining OWL and ruleML. 45. Kuba, K. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in ...

    2017 doi

  11. [46]

    & Munster, V

    Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature microbiology , doi:10.1038/s41564-020-0688-y (2020)

    2020 doi

  12. [47]

    Hoffmann, M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181 , 271-280 e278, doi:10.1016/j.cell.2020.02.052 (2020)

    2020 doi

  13. [48]

    Lim, S., & Johannesson, P. (2023). An Ontology to Bridge the Clinical Management of Patients and Public Health Responses for Strengthening Infectious Disease Surveillance: Design Science Study. JMIR Formative Research, 8 . 37 A Fourfold Pathogen Reference Ontology Suite

    2023

  14. [49]

    Patel, A., Debnath, N.C., Mishra, A.K., & Jain, S. (2021). Covid19-IBO: A Covid-19 Impact on Indian Banking Ontology Along with an Efficient Schema Matching Approach. New Generation Computing, 39 , 647 - 676

    2021

  15. [50]

    The HIVToolbox 2 web system integrates sequence, structure, Function and Mutation Analysis

    Sargeant D, Deverasetty S, Strong CL, Alaniz IJ, Bartlett A, Brandon NR, et al. The HIVToolbox 2 web system integrates sequence, structure, Function and Mutation Analysis. PLOS ONE. 2014;9(6):e98810. https://doi.org/10.1371/journal.pone.0098810. 51. Luciano J, Schriml L, Squir...

    2014 doi

  16. [52]

    Describing the breakbone fever: IDODEN, an ontology for dengue fever

    Mitraka E, Topalis P, Dritsou V, Dialynas E, Louis C. Describing the breakbone fever: IDODEN, an ontology for dengue fever. PLoS Negl Trop Dis. 2015;9(2):e0003479. https://doi.org/10.1371/journal.pntd.0003479. 53. Ananthanarayan, R. & Paniker, J. (2005). Textbook of Microbiolo...

    2005 doi

  17. [57]

    L., Pouch, S., Cowell, L

    Gordon, C. L., Pouch, S., Cowell, L. G., Boland, M. R., Platt, H. L., Goldfain, A., & Weng, C. (2013). Design and evaluation of a bacterial clinical infectious diseases ontology. AMIA. Annual Symposium proceedings. AMIA Symposium , 2013 , 502–511

    2013

  18. [61]

    IDOMEN: an extension of Infectious Disease Ontology for MENingitis

    Béré C, Camara G, Malo S, Lo M, Ouaro S. IDOMEN: an extension of Infectious Disease Ontology for MENingitis. In: Ohno-Machado L, Séroussi B, editors. MEDINFO 2019: health and wellbeing e-networks for all. Amsterdam: IOS Press; 2019. p. 313–7. https://pubmed.ncbi.nlm.nih.gov/31...

    2013

  19. [63]

    L., & Weng, C

    Gordon, C. L., & Weng, C. (2016). Bacterial clinical infectious diseases ontology (BCIDO) dataset. Data in brief , 8 , 881–884. https://doi.org/10.1016/j.dib.2016.07.018 64. Kõljalg, U., Nilsson, H. R., Schigel, D., Tedersoo, L., Larsson, K. -H., May, T. W., Taylor, A. F. S., ...

    2016 doi

  20. [65]

    Abarenkov K, Nilsson RH, Larsson K-H, Taylor AFS, May TW, Frøslev TG, Pawlowska J, Lindahl B, Põldmaa K, Truong C, Vu D, Hosoya T, Niskanen T, Piirmann T, Ivanov F, Zirk A, Peterson M, Cheeke TE, Ishigami Y, Jansson AT, Jeppesen TS, Kristiansson E, Mikryukov V, Miller JT, Oono...

    2010

  21. [71]

    Antifungal drug resistance of pathogenic fungi

    Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. The Lancet. 2002;359(9312):1135–1144. doi: 10.1016/S0140-6736(02)08162-X

    2002 doi

  22. [72]

    The global problem of antifungal resistance: prevalence, mechanisms, and management

    Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383-e92

    2017

  23. [74]

    Buttigieg, P.L., Morrison, N., Smith, B. et al. The environment ontology: contextualising biological and biomedical entities. J Biomed Semant 4 , 43 (2013). https://doi.org/10.1186/2041-1480-4-43 75. Hogan, W.R., Wagner, M.M., Brochhausen, M. et al. The Apollo Structured Vocab...

    2013 doi

  24. [76]

    Ong, E., Sun, P., Berke, K., Zheng, J., Wu, G., & He, Y. (2019). VIO: ontology classification and study of vaccine responses given various experimental and analytical conditions. BMC bioinformatics , 20 (Suppl 21), 704. https://doi.org/10.1186/s12859-019-3194-6 77. Lin Y, He Y...

    2019 doi

  25. [78]

    An annotated checklist of the eukaryotic parasites of humans, exclusive of fungi and algae

    Mathison BA, Sapp SGH. An annotated checklist of the eukaryotic parasites of humans, exclusive of fungi and algae. Zookeys. 2021 Nov 9;1069:1-313. doi: 10.3897/zookeys.1069.67403. PMID: 34819766; PMCID: PMC8595220

    2021

  26. [80]

    The Ontology for Parasite Lifecycle (OPL): towards a consistent vocabulary of lifecycle stages in parasitic organisms

    PP, Zheng J, Logan-Klumpler F, Stoeckert CJ Jr, Louis C, Topalis P, Protasio AV, Sheth AP, Carrington M, Berriman M, Sahoo SS. The Ontology for Parasite Lifecycle (OPL): towards a consistent vocabulary of lifecycle stages in parasitic organisms. J Biomed Semantics. 2012 May 23...

    2012 doi

  27. [81]

    Scheifler M, Ruiz-Rodríguez M, Sanchez-Brosseau S, Magnanou E, Suzuki MT, West N, Duperron S, Desdevises Y

    DPDx – Laboratory Identification of Parasites of Public Health Concern, accessed 09/26/2024 at https://www.cdc.gov/dpdx/az.html 82. Scheifler M, Ruiz-Rodríguez M, Sanchez-Brosseau S, Magnanou E, Suzuki MT, West N, Duperron S, Desdevises Y. Characterization of ecto- and endopar...

    2024 doi

  28. [83]

    Mungall, C.J., Torniai, C., Gkoutos, G.V. et al. Uberon, an integrative multi-species anatomy ontology. Genome Biol 13 , R5 (2012). https://doi.org/10.1186/gb-2012-13-1-r5

    2012 doi

  29. [84]

    F., Diehl, A

    Sarntivijai, S., Lin, Y., Xiang, Z., Meehan, T. F., Diehl, A. D., Vempati, U. D., Schürer, S. C., Pang, C., Malone, J., Parkinson, H., Liu, Y., Takatsuki, T., Saijo, K., Masuya, H., Nakamura, Y., Brush, M. H., Haendel, M. A., Zheng, J., Stoeckert, C. J., Peters, B., … He, Y. (...

    2014 doi

  30. [86]

    Updates on the web-based VIOLIN vaccine database and analysis system

    He Y, Racz R, Sayers S, et al. Updates on the web-based VIOLIN vaccine database and analysis system. Nucleic Acids Res. 2014;42(Database issue):D1124-D1132. doi:10.1093/nar/gkt1133

    2014 doi

  31. [87]

    M., Munro, J

    Schriml, L. M., Munro, J. B., Schor, M., Olley, D., McCracken, C., Felix, V., Baron, J. A., Jackson, R., Bello, S. M., Bearer, C., Lichenstein, R., Bisordi, K., Dialo, N. C., Giglio, M., & Greene, C. (2022). The Human Disease Ontology 2022 update. Nucleic acids research , 50 (...

    2022 doi

  32. [89]

    Topalis, P., Mitraka, E., Bujila, I., Deligianni, E., Dialynas, E., Siden-Kiamos, I., Troye-Blomberg, M., & Louis, C. (2010). IDOMAL: an ontology for malaria. Malaria journal , 9 , 230. https://doi.org/10.1186/1475-2875-9-230

    2010 doi

  33. [90]

    Camara, G., Despres, S., Djedidi, R., & Lo, M. (2013). Design of schistosomiasis ontology (IDOSCHISTO) extending the infectious disease ontology. Studies in health technology and informatics , 192 , 466–470

    2013

  34. [91]

    Measuring the Benefits of CI/CD Practices for Database. Application Development,

    J. Fluri, F. Fornari and E. Pustulka, "Measuring the Benefits of CI/CD Practices for Database. Application Development," 2023 IEEE/ACM International Conference on Software and System Processes (ICSSP), Melbourne, Australia, 2023, pp. 46-57, doi:10.1109/ICSSP59042.2023.00015

    2023

  35. [92]

    Jackson, R. C. et al. ROBOT: a tool for automating ontology workflows. BMC bioinformatics 20, 1–10, https://doi.org/10.1186/s12859-019-3002-3 (2019)

    2019 doi

  36. [93]

    Prudhomme, T., De Colle, G., Liebers, A. et al. A semantic approach to mapping the Provenance Ontology to Basic Formal Ontology. Sci Data 12, 282 (2025). https://doi.org/10.1038/s41597-025-04580-1 39

    2025 doi

  37. [2021]

    Goldfain, A., Cowell, L.G., & Smith, B

    19. Goldfain, A., Cowell, L.G., & Smith, B. (2012). Constructing a Lattice of Infectious Disease Ontologies from a Staphylococcus aureus Isolate Repository. International Conference on Biomedical Ontology

    2012

Pith tools

Reviewed August 10, 2026 · model on record in the stance chip above.